Please assess the completion status of the following clinical trial:

Trial Title: Influence of Mild Hypothermia on Reversal of Rocuronium With Sugammadex

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient for elective abdominal surgery from 20 years (yrs) to 65 yrs Patient in American Society of Anesthesiologists criteria 1 or 2 Patient in the supine position with arm available for neuromuscular monitoring during operation~Exclusion Criteria:~* Patients expected to have a difficult airway, known neuromuscular disease, significant hepatic or renal dysfunction, family history of malignant hyperthermia, known allergy to one of the drugs used in this protocol, intake of any medication that might interact with muscle relaxants, pregnant, or breast feeding

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- C group (Type: ACTIVE_COMPARATOR): normal thermal condition with core temperatures between 36.5°C and 37°C
- H group (Type: EXPERIMENTAL): mild hypothermia with core temperatures between 34.5°C and 35°C

Based on this trial design, predict the completion outcome and termination type (if applicable).